EVORANA Trademark

Trademark Overview


On Monday, December 20, 2021, a trademark application was filed for EVORANA with the United States Patent and Trademark Office. The USPTO has given the EVORANA trademark a serial number of 79332776. The federal status of this trademark filing is REGISTERED as of Tuesday, July 12, 2022. This trademark is owned by NOVARTIS AG. The EVORANA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
evorana

General Information


Serial Number79332776
Word MarkEVORANA
Filing DateMonday, December 20, 2021
Status700 - REGISTERED
Status DateTuesday, July 12, 2022
Registration Number6784285
Registration DateTuesday, July 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH

Trademark Events


Event DateEvent Description
Sunday, September 25, 2022NOTIFICATION PROCESSED BY IB
Tuesday, September 6, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 6, 2022FINAL DISPOSITION PROCESSED
Thursday, August 11, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 12, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 12, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, June 9, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, June 6, 2022ASSIGNED TO PETITION STAFF
Tuesday, May 17, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 17, 2022ASSIGNED TO EXAMINER
Monday, March 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 7, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 19, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 14, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 3, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB